DWP
IBB icon

Destiny Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Destiny Wealth Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.74M Sell
16,234
-60
-0.4% -$10.3K 0.3% 67
2025
Q4 		$2.87M Sell
16,294
-136
-0.8% -$22.1K 0.33% 62
2025
Q3 		$2.37M Sell
16,430
-59,354
-78% -$8.1M 0.29% 64
2025
Q2 		$9.59M Buy
75,784
+5,919
+8% +$727K 1.29% 26
2025
Q1 		$8.94M Buy
69,865
+4,358
+7% +$591K 1.42% 26
2024
Q4 		$8.66M Buy
65,507
+2,463
+4% +$346K 1.41% 23
2024
Q3 		$9.18M Sell
63,044
-13,556
-18% -$1.96M 1.61% 22
2024
Q2 		$10.5M Buy
76,600
+9,729
+15% +$1.3M 1.89% 15
2024
Q1 		$9.18M Buy
66,871
+1,041
+2% +$142K 1.64% 24
2023
Q4 		$8.99M Buy
65,830
+3,260
+5% +$398K 1.69% 23
2023
Q3 		$7.65M Buy
62,570
+933
+2% +$119K 1.54% 26
2023
Q2 		$8.1M Buy
61,637
+2,970
+5% +$386K 1.55% 22
2023
Q1 		$7.58M Buy
58,667
+8,488
+17% +$1.11M 1.57% 21
2022
Q4 		$6.59M Sell
50,179
-9,323
-16% -$1.2M 1.43% 24
2022
Q3 		$6.96M Buy
59,502
+1,599
+3% +$199K 1.56% 23
2022
Q2 		$6.81M Sell
57,903
-56
-0.1% -$6.65K 1.5% 24
2022
Q1 		$7.55M Buy
57,959
+41,088
+244% +$5.35M 1.47% 25
2021
Q4 		$2.58M Buy
16,871
+3,009
+22% +$466K 0.5% 53
2021
Q3 		$2.24M Sell
13,862
-2,016
-13% -$339K 0.45% 58
2021
Q2 		$2.6M Buy
15,878
+210
+1% +$32.3K 0.5% 54
2021
Q1 		$2.36M Sell
15,668
-858
-5% -$136K 0.49% 53
2020
Q4 		$2.5M Buy
+16,526
New +$2.36M 0.52% 51

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Destiny Wealth Partners's IBB Position: Q1 2026 in Review

Destiny Wealth Partners reduced its iShares Biotechnology ETF (IBB) stake by 0.37% in Q1 2026, selling an estimated $10.3K and leaving 16,234 shares worth $2.74M. The position accounts for 0.3% of the portfolio, ranked #67.

Destiny Wealth Partners first reported a position in IBB in Q4 2020 and has held it in 22 quarters since. The position peaked at $10.5M in Q2 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Destiny Wealth Partners held 16,234 shares of iShares Biotechnology ETF worth $2.74M as of Q1 2026.
  • Destiny Wealth Partners sold 60 iShares Biotechnology ETF shares in Q1 2026, an estimated $10.3K.
  • iShares Biotechnology ETF made up 0.3% of Destiny Wealth Partners's portfolio in Q1 2026, its #67 holding.
  • Destiny Wealth Partners first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 22 quarters since.
  • Destiny Wealth Partners's iShares Biotechnology ETF position peaked at $10.5M in Q2 2024.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Destiny Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.